Rapid Dose Therapeutics Signs Distribution Agreement for Product Line, Receives US$2.1 Million Purchase Order

Cannabis Investing News

Rapid Dose Therapeutics (CSE:DOSE) and Ukraine Pharma announced today that they have signed a twelve month distribution agreement to export QuickStrip™ nutraceutical products to Ukraine and other European countries, giving Rapid Dose Therapeutics the chance to market its products to a consumer base of over 200 million people. As quoted in the press release: The Agreement requires a minimum quarterly …

Rapid Dose Therapeutics (CSE:DOSE) and Ukraine Pharma announced today that they have signed a twelve month distribution agreement to export QuickStrip™ nutraceutical products to Ukraine and other European countries, giving Rapid Dose Therapeutics the chance to market its products to a consumer base of over 200 million people.

As quoted in the press release:

The Agreement requires a minimum quarterly order of one million of each of RDT’s Energy, B12, and Sleep QuickStrips™ and the Company has provided RDT with a signed purchase order for US$2.1 million.

RDT’s proprietary QuickStrip™ technology is a Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system that offers an Anytime, Anywhere™ product to consumers. Ukraine Pharma expects to distribute QuickStrip™ by the third calendar quarter of 2019.

“This represents the beginning of a growing opportunity for RDT to provide its QuickStrip™ products to people wanting an effective and innovative means of delivering nutraceuticals,” said Mark Upsdell, CEO of RDT. “The Agreement with Ukraine Pharma elevates QuickStrip™ as a growing international brand and delivery device to major market consumers, while simultaneously offering health benefits and improving patient outcomes.”

Click here to read the full press release.

The Conversation (0)
Ă—